Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
The occurrence of venous thromboembolism (VTE) is associated with poorer survival outcomes in women with cervical cancer.
Retrospective study that included 798 patients with stage I-IV cervical cancer cases diagnosed between 2000 and 2014 at a single academic institution.
Risk factors for VTE were examined, as well as the effect of VTE on survival outcomes.
Funding: No funding source disclosed.
VTE was recorded in 98 (12.3%) patients.
Albumin level at diagnosis, stage, and receipt of systemic chemotherapy were independent risk factors associated with development of VTE on multivariable analysis.
The risk of developing VTE during and within 1 mo after chemotherapy was significantly higher in patients receiving cisplatin and gemcitabine (11/42 cases, 26.2%) vs other regimens (0/38 cases; P<.001).
On multivariable analysis, VTE remained an independent prognostic factor as...